Product Description
Ref-SKU:
005V-03317 1 mL of clarified supernatant from monkeypox infected cells. Passage 2.
Product Risk Group:
ICTV Taxonomy:
Virus name:
Strain:
Isolate:
Genotype:
Storage conditions:
Viral Storage Medium -80C
Sequencing:
Complete genome
Infectivity:
Infectivity tested
Mycoplasmic content:
Not tested
GMO:
No
Biosafety restrictions:
All recipients must have proven capability to handle pathogens at BSL3. This is also an UK schedule 5 pathogen so recipient institutes may need additional approval to be able to receive the virus.
Virus host type:
Infectivity Test:
Plaque assay
Production cell line:
Genbank reference:
Virus Cultivability:
Passage:
Passage 2
Identification technique:
PCR and sequencing
Shipping conditions:
IATA Classification:
Note:
Please note: due to the current unprecedented demand for this product there may be an increased response time upon reciept of your order. Although we will endevour to provide the product as quickly as possible, we can provide no guarantees on when the order will be available for dispatch.
Information about the collection of the virus
Recombinant product:
No
Biological material origin:
Natural origin
Collection date:
Tuesday, 9 October, 2018
Country of collection:
Isolation host:
Isolation technique:
Cell culture
Comments (1)
According to the Interim Recommendations of the WHO Directorate-General in connection with the outbreak of monkeypox, it is indicated that participating States with medical countermeasures to take should increase the availability and capacity for the diagnosis of monkeypox, the production of vaccines. Therefore, the virus will be used for scientific purposes in diagnosing poxviruses.